Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline crossover trial for excessive daytime sleepiness in Parkinson's disease
NL-OMON43609Phase 3Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of varenicline in Parkinson's disease (PD) (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Epworth Sleepiness Scale difference between varenicline and placebo. Started May 2013; status: active, not recruiting.
02
Drugs
varenicline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON43609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43609.